SABCS 2023 | Role of T-DXd in patients with HER2+ or HER2-low BC and leptomeningeal carcinomatosis

Marta Vaz Batista, MD, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal, talks on the challenges of leptomeningeal carcinomatosis for patients with advanced breast cancer, and the limited treatment options available to patients. Dr Vaz Batista gives her thoughts on the role of trastuzumab deruxtecan (T-DXd) and how it may evolve in the management of this patient population. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.